reference/6106123

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6106123

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	150
issn	1353-8020
pageRange	144-150
publicationName	Parkinsonism & Related Disorders
startingPage	144
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4509ad53ec8734defd8c64f6527e50cc http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3f1180781244eb941449bc4cd27c5b61 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e14c5507c14c2ba30c06e062838cf6a1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7c345d67a24ab2a81f0393b14b3da021 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e9cb3508a4bc309edf41720432197ad9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ddc997663e20581ceb1154bb4fe91bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_525e6c97d492b01d3922ef3cf8c764b4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3c9f196fd252e491b4e5ee64ec3f902e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1f4df9a67aa20035457ec07306b401e5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5aea6385a2ebcacfb6f0cd0d27d53aa5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8f9d0ecc084b8bb3fe377e1dd6f1cd4e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6b21d07ab7be7db63d150c6021004928 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_03d7dfd408d49d1fee65c16c849e4c1b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_26fba9456e1e33d5671ff7055ed23621 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fe6c8a693830c51fb8465c675b260469 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4170acd6af571e8d0d59fdad999cc605 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_66c1d5fcf3aae825db11f29b93ee74b9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3c3cd0e475b3e8b6050d12ce5ac047ca http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b4888dcc70ab184e6233661e28310a62 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b34193a9204d2f50d15aedf8b222dbad
bibliographicCitation	Farbman ES, Waters CH, LeWitt PA, Rudzińska M, Klingler M, Lee A, Qian J, Oh C, Hauser RA. A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease. Parkinsonism Relat Disord. 2020 Dec;81():144–50. doi: 10.1016/j.parkreldis.2020.10.029. PMID: 33130477.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c349461134468206469dfb0f825f7b5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e415fe737a3acae44fc9b0412a53ce8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b93cd3227fb822729ca17211fbf08374 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebc029d45cbb0557a2f9de71c9d1649b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58e833be49a06e0b8dfeeda6bb9e5767 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8adcb4d555509ee9384e5770dbf9306b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21f38f9400986236c5a5035921509fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a184dca386fc9a17b206ffa981bcb70b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adc4d820d5966366997b69dad44f17d6
date	202012
identifier	https://pubmed.ncbi.nlm.nih.gov/33130477 https://doi.org/10.1016/j.parkreldis.2020.10.029
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21522 https://portal.issn.org/resource/ISSN/1353-8020
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
discusses	http://id.nlm.nih.gov/mesh/M0027733 http://id.nlm.nih.gov/mesh/M0539798 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0017411 http://id.nlm.nih.gov/mesh/M0003345 http://id.nlm.nih.gov/mesh/M0012434
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018491Q000494 http://id.nlm.nih.gov/mesh/D017063 http://id.nlm.nih.gov/mesh/D007980Q000494 http://id.nlm.nih.gov/mesh/D064420
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013147 http://id.nlm.nih.gov/mesh/D007980Q000009 http://id.nlm.nih.gov/mesh/D007980Q000008 http://id.nlm.nih.gov/mesh/D018491Q000009 http://id.nlm.nih.gov/mesh/D018491Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000280 http://id.nlm.nih.gov/mesh/D011208 http://id.nlm.nih.gov/mesh/D002230Q000494 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016037 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7353 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10647 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9083 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104778

Showing number of triples: 1 to 76 of 76.